Multivariate analysis of the pathologic features of esophageal squamous cell cancer: Tumor budding is a significant independent prognostic factor

Annals of Surgical Oncology

Volumn 15, Issue 7, 2008, Pages 1977-1982

  Koike, Masahiko ^a   Kodera, Yasuhiro ^a   Itoh, Yuichi ^a   Nakayama, Goro ^a   Fujiwara, Michitaka ^a   Hamajima, Nobuyuki ^a   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Esophageal cancer; Esophagectomy; Prognosis; Squamous cell cancer; Tumor budding

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORPHOLOGY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

AGED; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, SQUAMOUS CELL; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 46149101993     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9901-6     Document Type: Article

References (28)

1. Ando N, Ozawa S, Kitagawa Y, et al. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000; 232:225-32
2. Ando N, Iizuka T, Ide H, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 2003; 21:4592-6
3. Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet 1987; 1:1303-6
4. Deans GT, Heatley M, Anderson N, et al. Jass' classification revisited. J Am Coll Surg 1994; 179:11-17
5. Jass JR, Ajioka Y, Allen JP, et al. Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology 1996; 28:543-8
6. Morodomi T, Isomoto H, Shirouzu K, et al. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 1989; 63:539-43
7. Ueno H, Murphy J, Jass JR, et al. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002; 40:127-32
8. Okuyama T, Oya M, Ishikawa H. Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma. J Surg Oncol 2003; 83:42-7
9. Roh MS, Lee JI, Choi PJ. Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma. Dis Esophagus 2004; 17:333-7
10. Diseases Jsfe. Guidelines for clinical and pathologic studies on carcinoma of the esophagus, ninth edition: part 2. Esophagus 2004; 1:107-25
11. Hase K, Shatney C, Johnson D, et al. Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum 1993; 36:627-35
12. Jass JR, Barker M, Fraser L, et al. APC mutation and tumour budding in colorectal cancer. J Clin Pathol 2003; 56:69-73
13. Ueno H, Price AB, Wilkinson KH, et al. A new prognostic staging system for rectal cancer. Ann Surg 2004; 240:832-9
14. Lieberman MD, Shriver CD, Bleckner S, et al. Carcinoma of the esophagus. Prognostic significance of histologic type. J Thorac Cardiovasc Surg 1995; 109:130-8; discussion 139
15. Siewert JR, Stein HJ, Feith M, et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001; 234:360-7; discussion 368-9
16. Theunissen PH, Borchard F, Poortvliet DC. Histopathological evaluation of oesophageal carcinoma: the significance of venous invasion. Br J Surg 1991; 78:930-2
17. Edwards JM, Hillier VF, Lawson RA, et al. Squamous carcinoma of the oesophagus: histological criteria and their prognostic significance. Br J Cancer 1989; 59:429-33
18. Zafirellis K, Dolan K, Fountoulakis A, et al. Multivariate analysis of clinical, operative and pathologic features of esophageal cancer: who needs adjuvant therapy? Dis Esophagus 2002; 15:155-9
19. Ide H, Nakamura T, Hayashi K, et al. Esophageal squamous cell carcinoma: pathology and prognosis. World J Surg 1994; 18:321-30
20. Takubo K, Sasajima K, Yamashita K, et al. Prognostic significance of intramural metastasis in patients with esophageal carcinoma. Cancer 1990; 65:1816-9
21. Dexter SP, Sue-Ling H, McMahon MJ, et al. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut 2001; 48:667-70
22. Sugimachi K, Matsuoka H, Ohno S, et al. Multivariate approach for assessing the prognosis of clinical oesophageal carcinoma. Br J Surg 1988; 75:1115-8
23. Diseases Jsfe. Guideline for diagnosis and treatment of esophageal cancer. 2007; 10-11
24. Shimizu Y, Tsukagoshi H, Fujita M, et al. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc 2002; 56:387-90
25. Ono M, Sakamoto M, Ino Y, et al. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis. Cancer 1996; 78:1179-86
26. Gabbert H, Wagner R, Moll R, et al. Tumor dedifferentiation: an important step in tumor invasion. Clin Exp Metastasis 1985; 3:257-79
27. Prall F. Tumour budding in colorectal carcinoma. Histopathology 2007; 50:151-62
28. Gavert N, Conacci-Sorrell M, Gast D, et al. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 2005; 168:633-42